Lypd3 - Ly6/Plaur domain containing 3 Gene

Also Known as C4.4a; 2310061G07Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 72434

Summary

Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Predicted to be located in membrane. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Is expressed in several structures, including epithelium; foregut; sensory organ; skin; and thymus. Orthologous to human LYPD3 (LY6/PLAUR domain containing 3). [provided by Alliance of Genome Resources, Apr 2022]

Lypd3 Products (1)

mRNA Protein Name
NM_133743.1 NP_598504.1 ly6/PLAUR domain-containing protein 3 precursor
Protein Preferred Names Protein Names

ly6/PLAUR domain-containing protein 3

  • GPI-anchored metastasis-associated protein C4.4A homolog

  • GPI-anchored metastasis-associated protein homolog

Recombinant Lypd3 Proteins

Cat. No. Product Name Accession Purity
HY-P76483 LYPD3/C4.4A Protein, Mouse (HEK293, His) Q91YK8 (L33-H287) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99719 Lupartumab Amadotin 99.61% Phase 1
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99718 Lupartumab 99.52% Phase 1

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-147281 BAY 1135626 99.19% Unkown
HY-RS07917 LYPD3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17704 Lypd3 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24168 Lypd3 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P992360 GT-002 Modulator / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Lypd3 NCBI NCBI:27076